Every New Reactor Needs Fuel: 3 Uranium Stocks Positioned for the Nuclear Buildout24/7 Wall Street • 09/19/26
EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific CustomerGlobeNewsWire • 06/22/26
AIRO Debuts RQ-70 Long-Range ISR Drone Platform at Eurosatory 2026, Advancing Multi-Product Growth StrategyBusiness Wire • 06/18/26
Eviden and Hexadrone combine their expertise to equip modular drones with SIGINT capabilitiesGlobeNewsWire • 06/16/26
Perspective Therapeutics Expands Management Team And Names Andrew Bright as Executive Vice-President of BrachytherapyGlobeNewsWire • 04/03/23
Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King's College London to Support Radiobiology Research of Alpha Particle Therapy for CancerGlobeNewsWire • 03/08/23
Initial Results From First Patient Dosed With Perspective Therapeutics' Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific SessionGlobeNewsWire • 02/22/23
Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022GlobeNewsWire • 02/16/23
Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.GlobeNewsWire • 02/07/23
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology MedicineBusiness Wire • 02/06/23
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023GlobeNewsWire • 01/12/23
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023GlobeNewsWire • 12/14/22
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022GlobeNewsWire • 12/14/22
ISORAY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Isoray, Inc - ISRBusiness Wire • 11/12/22
Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending MergerGlobeNewsWire • 11/10/22
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022GlobeNewsWire • 10/31/22
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDTBusiness Wire • 10/18/22
ISR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Isoray, Inc. Is Fair to ShareholdersBusiness Wire • 09/29/22